Immunochemotherapy is the standard of care in elderly patients with diffuse large B-cell lymphoma

被引：5
|
作者：
Coiffier, B [1 ]
Salles, G [1 ]
机构：
[1] Ctr Hosp Lyon Sud, Dept Hematol, F-69495 Pierre Benite, France
来源：
BLOOD | 2004年 / 104卷 / 05期
关键词：
D O I：
10.1182/blood-2004-04-1266
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1584 / 1585
页数：2
相关论文
共 50 条
  • [41] Incidence and Outcomes of Treatment Refractory Diffuse Large B-Cell Lymphoma in the Immunochemotherapy Era
    Maurer, Matthew J.
    Thompson, Carrie A.
    Farooq, Umar
    Lin, Tasha
    Nowakowski, Grzegorz S.
    Lin, Yi
    Micallef, Ivana
    Novak, Anne
    Macon, William
    Syrbu, Sergei
    Cerhan, James
    Witzig, Thomas E.
    Habermann, Thomas M.
    Ansell, Stephen
    Link, Brian K.
    BLOOD, 2015, 126 (23)
  • [42] The Geriatric Prognostic Index: a clinical prediction model for survival of older diffuse large B-cell lymphoma patients treated with standard immunochemotherapy
    Isaksen, Kathrine T.
    Galleberg, Renate
    Mastroianni, Maria Adele
    Rinde, Marit
    Rusten, Leiv Sindre
    Barzenje, Dlawer
    Ramslien, Frode
    Fluge, Oystein
    Slaaen, Marit
    Meyer, Peter
    Liestol, Knut
    Smeland, Erlend B.
    Lingjaerde, Ole Christian
    Holte, Harald
    Brodtkorb, Marianne
    HAEMATOLOGICA, 2023, 108 (09) : 2454 - 2466
  • [43] Evaluating the cancer aging and research group model in predicting immunochemotherapy toxicity among elderly patients with diffuse large B-cell lymphoma
    Hung, Yu-Shin
    Hung, Chia-Yen
    Chou, Wen-Chi
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 138
  • [44] Diffuse Large B-Cell Lymphoma in the Elderly: Outcome of Patients From a Single Center
    De Colella, Jean-Marc Schiano
    Coso, Diane
    Esterni, Benjamin
    Stoppa, Anne-Marie
    Ivanov, Vadim
    Aurran, Therese
    Broussais, Florence
    Rey, Jerome
    Rousseau, Frederique
    Cecile, Maud
    Blaise, Didier
    Bouabdallah, Reda
    BLOOD, 2011, 118 (21) : 1157 - 1157
  • [45] Prognostic Factors in Elderly Patients with Diffuse Large B-Cell Lymphoma and Their Treatment Results
    Adiyaman, Suleyman Cem
    Alacacioglu, Inci
    Danyeli, Ayca Ersen
    Turkyilmaz, Dogus
    Sevindik, Omur Gokmen
    Demirkan, Fatih
    Piskin, Ozden
    Ozcan, Mehmet Ali
    Undar, Bulent
    Ozkal, Sermin
    Ozsan, Guner Hayri
    TURKISH JOURNAL OF HEMATOLOGY, 2019, 36 (02) : 81 - 87
  • [46] Treatment Decisions and Outcome in Very Elderly Patients With Diffuse Large B-Cell Lymphoma
    Fabbri, Alberto
    Cencini, Emanuele
    Bocchia, Monica
    CANCER, 2015, 121 (20) : 3746 - 3747
  • [47] Rebirth of radiotherapy for elderly patients with diffuse large B-cell lymphoma in the rituximab era
    Flowers, Christopher R.
    Cohen, Jonathon B.
    Khan, Mohammad K.
    LEUKEMIA & LYMPHOMA, 2015, 56 (03) : 557 - 558
  • [48] IMPACT OF RITUXIMAB ON OUTCOMES OF VERY ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
    Lee, L.
    Khor, S.
    Hoch, J. S.
    Luo, J.
    Bremner, K.
    Krahn, M.
    Crump, M.
    Hodgson, D. C.
    ANNALS OF ONCOLOGY, 2011, 22 : 195 - 195
  • [49] Evaluation of the impact of maintenance rituximab in elderly patients with diffuse large B-cell lymphoma
    不详
    CLINICAL LYMPHOMA & MYELOMA, 2007, 7 (07): : 456 - 457
  • [50] Management Strategies and Outcomes for Very Elderly Patients With Diffuse Large B-Cell Lymphoma
    Chihara, Dai
    Westin, Jason R.
    Oki, Yasuhiro
    Ahmed, Mohamed A.
    Do, Bryan
    Fayad, Luis E.
    Hagemeister, Fredrick B.
    Romaguera, Jorge E.
    Fanale, Michelle A.
    Lee, Hun J.
    Turturro, Francesco
    Samaniego, Felipe
    Neelapu, Sattva S.
    Rodriguez, M. Alma
    Fowler, Nathan H.
    Wang, Michael
    Davis, Richard E.
    Nastoupil, Loretta J.
    CANCER, 2016, 122 (20) : 3145 - 3151
12345